🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
OAB
$OABI
🔒 US EquitiesOmniAb Inc
AVG HISTORICAL GAP
+1.64%
MAX GAP RECORD
+17.38%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $OABI
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$OABI
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE) |
+5.80%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
+4.76%
|
| Mar 04, 2026 Earnings Release 2026-03-04 (AFTER CLOSE) |
+0.00%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (AFTER CLOSE) |
-2.70%
|
| Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE) |
-1.04%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
+1.63%
|
| Mar 18, 2025 Earnings Release 2025-03-18 (AFTER CLOSE) |
-4.39%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE) |
-10.91%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.2%
Bullish Gaps (6)
Bearish Gaps (5)
Neutral / Flat (1)
📖 Intelligence Summary
OmniAb, Inc. operates as a drug discovery company. The firm focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗